164 related articles for article (PubMed ID: 12218163)
1. TCR rearrangement in lymphocytes infiltrating melanoma metastases after administration of autologous dinitrophenyl-modified vaccine.
Manne J; Mastrangelo MJ; Sato T; Berd D
J Immunol; 2002 Sep; 169(6):3407-12. PubMed ID: 12218163
[TBL] [Abstract][Full Text] [Related]
2. Clonal expansion of T lymphocytes in human melanoma metastases after treatment with a hapten-modified autologous tumor vaccine.
Sensi M; Farina C; Maccalli C; Lupetti R; Nicolini G; Anichini A; Parmiani G; Berd D
J Clin Invest; 1997 Feb; 99(4):710-7. PubMed ID: 9045874
[TBL] [Abstract][Full Text] [Related]
3. T cell receptor (TCR) structure of autologous melanoma-reactive cytotoxic T lymphocyte (CTL) clones: tumor-infiltrating lymphocytes overexpress in vivo the TCR beta chain sequence used by an HLA-A2-restricted and melanocyte-lineage-specific CTL clone.
Sensi M; Salvi S; Castelli C; Maccalli C; Mazzocchi A; Mortarini R; Nicolini G; Herlyn M; Parmiani G; Anichini A
J Exp Med; 1993 Oct; 178(4):1231-46. PubMed ID: 8376931
[TBL] [Abstract][Full Text] [Related]
4. Two autologous melanoma-specific and MHC-restricted human T cell clones with identical intra-tumour reactivity do not share the same TCR V alpha and V beta gene families.
Sensi M; Castelli C; Anichini A; Grossberger D; Mazzocchi A; Mortarini R; Parmiani G
Melanoma Res; 1991; 1(4):261-71. PubMed ID: 1668534
[TBL] [Abstract][Full Text] [Related]
5. Large and dissimilar repertoire of Melan-A/MART-1-specific CTL in metastatic lesions and blood of a melanoma patient.
Mandruzzato S; Rossi E; Bernardi F; Tosello V; Macino B; Basso G; Chiarion-Sileni V; Rossi CR; Montesco C; Zanovello P
J Immunol; 2002 Oct; 169(7):4017-24. PubMed ID: 12244204
[TBL] [Abstract][Full Text] [Related]
6. T-cell receptor beta variable region diversity in melanoma metastases after interleukin 2-based immunotherapy.
Willhauck M; Möhler T; Scheibenbogen C; Pawlita M; Brossart P; Schmier JW; Keilholz U
Clin Cancer Res; 1996 Apr; 2(4):767-72. PubMed ID: 9816229
[TBL] [Abstract][Full Text] [Related]
7. Analysis of T cell receptor alpha beta variability in tumor-infiltrating lymphocytes in primary and metastatic melanoma.
Zeuthen J; Birck A; Straten PT
Arch Immunol Ther Exp (Warsz); 1995; 43(2):123-33. PubMed ID: 8744727
[TBL] [Abstract][Full Text] [Related]
8. Polyclonal uses of T-cell receptor (TCR)alpha and beta genes for cytotoxic T lymphocytes in human metastatic melanoma: possible involvement of TCR alpha in tumor-cell recognition.
Seito D; Morita T; Masuoka K; Maeda T; Saya H; Itoh K
Int J Cancer; 1994 Aug; 58(4):497-502. PubMed ID: 8056445
[TBL] [Abstract][Full Text] [Related]
9. Comparative assessment of TCRBV diversity in T lymphocytes present in blood, metastatic lesions, and DTH sites of two melanoma patients vaccinated with an IL-7 gene-modified autologous tumor cell vaccine.
Carsana M; Tragni G; Nicolini G; Bersani I; Parmiani G; Anichini A; Sun YS; Möller P; Schadendorf D; Sensi ML
Cancer Gene Ther; 2002 Mar; 9(3):243-53. PubMed ID: 11896440
[TBL] [Abstract][Full Text] [Related]
10. Vaccination with a Melan-A peptide selects an oligoclonal T cell population with increased functional avidity and tumor reactivity.
Valmori D; Dutoit V; Schnuriger V; Quiquerez AL; Pittet MJ; Guillaume P; Rubio-Godoy V; Walker PR; Rimoldi D; Liénard D; Cerottini JC; Romero P; Dietrich PY
J Immunol; 2002 Apr; 168(8):4231-40. PubMed ID: 11937585
[TBL] [Abstract][Full Text] [Related]
11. Selective growth, in vitro and in vivo, of individual T cell clones from tumor-infiltrating lymphocytes obtained from patients with melanoma.
Zhou J; Dudley ME; Rosenberg SA; Robbins PF
J Immunol; 2004 Dec; 173(12):7622-9. PubMed ID: 15585890
[TBL] [Abstract][Full Text] [Related]
12. Construction and binding analysis of recombinant single-chain TCR derived from tumor-infiltrating lymphocytes and a cytotoxic T lymphocyte clone directed against MAGE-1.
Lake DF; Salgaller ML; van der Bruggen P; Bernstein RM; Marchalonis JJ
Int Immunol; 1999 May; 11(5):745-51. PubMed ID: 10330280
[TBL] [Abstract][Full Text] [Related]
13. A particular TCR beta variable region used by T cells infiltrating kidney transplants.
Baron C; Sachs DH; LeGuern C
J Immunol; 2001 Feb; 166(4):2589-96. PubMed ID: 11160320
[TBL] [Abstract][Full Text] [Related]
14. T-cell receptor usage by melanoma-specific clonal and highly oligoclonal tumor-infiltrating lymphocyte lines.
Shilyansky J; Nishimura MI; Yannelli JR; Kawakami Y; Jacknin LS; Charmley P; Rosenberg SA
Proc Natl Acad Sci U S A; 1994 Mar; 91(7):2829-33. PubMed ID: 7511820
[TBL] [Abstract][Full Text] [Related]
15. Oligoclonal T cells are infiltrating the brains of children with AIDS: sequence analysis reveals high proportions of identical beta-chain T-cell receptor transcripts.
Lin WL; Fincke JE; Sharer LR; Monos DS; Lu S; Gaughan J; Platsoucas CD; Oleszak EL
Clin Exp Immunol; 2005 Aug; 141(2):338-56. PubMed ID: 15996199
[TBL] [Abstract][Full Text] [Related]
16. In-vivo dominant immune responses in aplastic anaemia: molecular tracking of putatively pathogenetic T-cell clones by TCR beta-CDR3 sequencing.
Risitano AM; Maciejewski JP; Green S; Plasilova M; Zeng W; Young NS
Lancet; 2004 Jul 24-30; 364(9431):355-64. PubMed ID: 15276395
[TBL] [Abstract][Full Text] [Related]
17. T cell receptor CDR3 loop length repertoire is determined primarily by features of the V(D)J recombination reaction.
Hughes MM; Yassai M; Sedy JR; Wehrly TD; Huang CY; Kanagawa O; Gorski J; Sleckman BP
Eur J Immunol; 2003 Jun; 33(6):1568-75. PubMed ID: 12778474
[TBL] [Abstract][Full Text] [Related]
18. High frequency of T cell clonal expansions in primary human melanoma. Involvement of a dominant clonotype in autologous tumor recognition.
Pisarra P; Mortarini R; Salvi S; Anichini A; Parmiani G; Sensi M
Cancer Immunol Immunother; 1999 Apr; 48(1):39-46. PubMed ID: 10235487
[TBL] [Abstract][Full Text] [Related]
19. Role of the complementarity-determining region 3 (CDR3) of the TCR-beta chains associated with the V alpha 14 semi-invariant TCR alpha-chain in the selection of CD4+ NK T Cells.
Ronet C; Mempel M; Thieblemont N; Lehuen A; Kourilsky P; Gachelin G
J Immunol; 2001 Feb; 166(3):1755-62. PubMed ID: 11160221
[TBL] [Abstract][Full Text] [Related]
20. Intralesional selection of T cell clonotypes in the immune response to melanoma antigens occurring during vaccination.
Sensi M; Farina C; Maccalli C; Anichini A; Berd D; Parmiani G
J Immunother; 1998 May; 21(3):198-204. PubMed ID: 9610911
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
